Nominations sought for 2027 Watanabe Prize in Translational Research
The Indiana University School of Medicine is accepting nominations for the 2027 August M. Watanabe Prize in Translational Research.
Pain researcher mixes preclinical, clinical research to study chronic pain in patients with mild traumatic brain injuries
Fletcher White leads a research team investigating how chronic pain develops in patients who have a history of mild traumatic brain injuries.
Beyond dialysis: Research, individualized interventions and education revolutionize kidney care
During National Kidney Awareness Month, members of the Division of Nephrology reflect on their passion for improving treatments and preventing kidney diseases.
IU research brings kidney stone care into a new era
Kidney stone rates are increasing worldwide, but treatments have remained the same for over 50 years. New efforts led by IU researchers aim to change
IU neurosurgeon revolutionizing hydrocephalus care for children with innovative research
Jason Chu is part of a team of researchers in the Department of Neurological Surgery leading efforts to develop new, safe therapies for patients of
Leading drug discovery: New department chair building team of researchers to develop next-gen treatments for diseases
As chair of the new Department of Biochemistry, Molecular Biology and Pharmacology, John Turchi is building a team of researchers to accelerate scientific discovery and
New study identifies tool to measure heart disease risk in testicular cancer survivors
New study finds equations can identify testicular cancer survivors who are at high risk of cardiovascular disease.
IU research contributes to first new non-hormonal copper IUD in 40 years
Indiana University hosted part of a clinical trial that ultimately led to FDA approval of a second type of copper nonhormonal IUD.
Fellow pioneers Indiana's first pediatric neuroimmunology clinic
The new neuroimmunology clinic at Riley Children’s Health will provide multidisciplinary care for Hoosier children living with multiple sclerosis and other neuroinflammatory disorders.
Study finds genetic risk factor for Alzheimer’s disease disrupts brain connectivity
A well-known genetic risk factor for Alzheimer’s disease worsens damage to white matter tissues in the brain that are crucial for communication between different brain